Rash, pruritus, and anemia more frequent among telaprevir-treated patients vs control patients
* Severe rash rare, but more frequent among telaprevir-treated patients
vs control patients (3% to 5%
vs 0%, respectively)
* Rash maculopapular in appearance
* Median time to rash appearance: 7-28 days
http://www.clinicaloptions.com/Hepatitis/Journal%20Options/Collections/2010%20JO%20Hepatitis%20Volume%204/Articles/McHutchison-NEJM-2010/Capsule.